ADMA Biologics (Nasdaq: ADMA), an innovator in the manufacturing and sale of intravenous immunoglobulin (IVIG) medicine, delivered a 23 minute presentation June 6th at the Jefferies 2019 Healthcare … [Read more...] about A Look At ADMA Biologics Investor Presentation At Jefferies 2019 Healthcare Conference
ADMA
Are Law Firms Unfairly Targeting Biotech?
Background Today one of our top picks for 2019 "ADMA" saw significant downside after news of Purcell Julie & Leftowitz LLP intention to investigate ADMA for "potential breaches of fiduciary … [Read more...] about Are Law Firms Unfairly Targeting Biotech?
ADMA Supply & Demand
ADMA #VolatilityWatch by follow_the_money on TradingView.com Supply and demand trade that will make money, even in a Bear market. ADMA Biologics (Nasdaq: ADMA) is a great defensive play, … [Read more...] about ADMA Supply & Demand
ADMA Presents Potential Entry For Investors On The Sideline
Today Adma Biologics (Nasdaq: ADMA) sold off ~10% closing at $3.50. Most of us already in Adma were not phased. Personally, I saw this as a healthy pullback. Since February 1st ADMA has gained 25% … [Read more...] about ADMA Presents Potential Entry For Investors On The Sideline
ADMA Enters Into $72.5 Million Loan Facility With Perceptive Advisors
Today ADMA Biologics (Nasdaq: ADMA) announced that they entered into a senior secured loan term facility with Perceptive Advisors for up to $72.5 million under 2 funding tranches. Let's get clarify … [Read more...] about ADMA Enters Into $72.5 Million Loan Facility With Perceptive Advisors
MS Identified Its Next Swing
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Preface WOW. We are absolutely elated with the performance of our last swing move on SCYX. In case you missed it on … [Read more...] about MS Identified Its Next Swing
ADMA Tanks After Receiving A CRL For BIVIGAM’s PAS Submission -Should You Buy?
Introduction Adma Biologics (Nasdaq: ADMA $2.23) is a commercial bio-pharmaceutical company vertically integrated to develop, market, manufacture, and sell specialty plasma-derived products called … [Read more...] about ADMA Tanks After Receiving A CRL For BIVIGAM’s PAS Submission -Should You Buy?
Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath
Overview Wednesday October 24th, 2018 the stock market was slashed across the board with the DOW erasing all its gains for the year and dripping red. The Nasdaq was hit with equal force. Comments from … [Read more...] about Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath
You must be logged in to post a comment.